KALOS MANAGEMENT, INC. – BioCryst Pharmaceuticals, Inc. Transaction History
KALOS MANAGEMENT, INC. portfolio value:
$0
portfolio value
KALOS MANAGEMENT, INC. quarter portfolio value change:
+19.09%
quarter
BioCryst Pharmaceuticals, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -100.00% | -23.9K shares | -256K | $12.6 | 0 |
| Q2 2022 | share | Increase | +1.92% | 450 shares | -125K | $10.58 | 23.9K |
| Q1 2022 | share | Decrease | -7.53% | -1.90K shares | 41K | $16.26 | 23.45K |
| Q4 2021 | share | Increase | +7.00% | 1.65K shares | 22K | $13.79 | 25.35K |
| Q3 2021 | share | Decrease | -1.46% | -350 shares | -77K | $14.37 | 23.7K |
| Q2 2021 | share | 0.00% | 0 shares | 135K | $15.81 | 24.05K | |
| Q1 2021 | share | Increase | +1.05% | 250 shares | 83K | $10.17 | 24.05K |
| Q4 2020 | share | Decrease | -4.03% | -1K shares | 88K | $7.45 | 23.8K |
| Q3 2020 | share | Increase | +30.87% | 5.85K shares | -1K | $3.44 | 24.8K |
| Q2 2020 | share | 0.00% | 0 shares | 53K | $4.76 | 18.95K | |
| Q1 2020 | share | Increase | 0.00% | 18.95K shares | 37K | $2 | 18.95K |
| Q4 2019 | share | Decrease | -100.00% | -18.95K shares | -53K | $3.45 | 0 |
| Q3 2019 | share | Increase | 0.00% | 18.95K shares | 53K | $2.87 | 18.95K |
| Q2 2019 | share | Decrease | -100.00% | -27.44K shares | -223K | $3.79 | 0 |
| Q1 2019 | share | Decrease | -4.38% | -1.25K shares | -28K | $8.14 | 27.44K |
| Q4 2018 | share | Decrease | -8.89% | -2.8K shares | 10K | $8.07 | 28.7K |
| Q3 2018 | share | Decrease | -3.08% | -1K shares | 85K | $7.63 | 31.5K |
| Q2 2018 | share | 0.00% | 0 shares | 0 | $5.73 | 32.5K | |
| Q1 2018 | share | Decrease | -2.99% | -1K shares | -8K | $4.77 | 32.5K |
| Q4 2017 | share | Increase | 0.00% | 33.5K shares | 164K | $4.91 | 33.5K |